Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children. (abre nova janela)

Ali S, Gassas A, Kirby-Allen M, Krueger J, Ali M, Schechter T

Fonte‎: Pediatr Transplant 2017;21(6):e13017.

Indexado‎: PubMed 28653480

DOI‎: 10.1111/petr.13017

https://www.ncbi.nlm.nih.gov/pubmed/28653480 (abre nova janela)

The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes. (abre nova janela)

Bhatia M, Davenport V, Cairo MS.

Fonte‎: Leuk Lymphoma 2007;48(1):9-15.

Indexado‎: PubMed 17325843

DOI‎: 10.1080/10428190600909115

https://www.ncbi.nlm.nih.gov/pubmed/17325843 (abre nova janela)

Recombinant human interleukin 11 and bacterial infection in patients with haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial. (abre nova janela)

Ellis M, Zwaan F, Hedström U, Poynton C, Kristensen J, Jumaa P, Wassell J, al-Ramadi B.

Fonte‎: Lancet 2003;361(9354):275-80.

Indexado‎: PubMed 12559860

https://www.ncbi.nlm.nih.gov/pubmed/12559860 (abre nova janela)

Romiplostim for immune thrombocytopenia in neuroblastoma patients receiving chemotherapy. (abre nova janela)

Fassel H, Bussel JB, Roberts SS, Modak S

Fonte‎: J Pediatr Hematol Oncol 2019;41(4):e257-9.

Indexado‎: PubMed 29683946

DOI‎: 10.1097/MPH.0000000000001187

https://www.ncbi.nlm.nih.gov/pubmed/29683946 (abre nova janela)

Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. (abre nova janela)

Jacobson AE, Shah N, Setty BA

Fonte‎: Pediatr Blood Cancer 2017;64(8):e26473.

Indexado‎: PubMed 28150377

DOI‎: 10.1002/pbc.26473

http://www.ncbi.nlm.nih.gov/pubmed/28150377 (abre nova janela)

Eltrombopag for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation in children. (abre nova janela)

Li S, Wu R, Wang B, Fu L, Zhu G, Zhou X, Ma J, Zhang L, Qin M

Fonte‎: J Pediatr Hematol Oncol 2019;41(1):38-41.

Indexado‎: PubMed 30080752

DOI‎: 10.1097/MPH.0000000000001263

https://www.ncbi.nlm.nih.gov/pubmed/30080752 (abre nova janela)

Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children. (abre nova janela)

Maximova N, Zanon D, Rovere F, Maestro A, Schillani G, Paparazzo R

Fonte‎: Int J Hematol 2015;102(5):626-32.

Indexado‎: PubMed 26084627

DOI‎: 10.1007/s12185-015-1821-1

https://www.ncbi.nlm.nih.gov/pubmed/26084627 (abre nova janela)

Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: a randomized, double-blind, placebo-controlled trial. (abre nova janela)

Porter JC, Leahey A, Polise K, Bunin G, Manno CS

Fonte‎: J Pediatr 1996;129(5):656-60.

Indexado‎: PubMed 8917229

DOI‎: 10.1016/s0022-3476(96)70145-2

https://www.ncbi.nlm.nih.gov/pubmed/8917229 (abre nova janela)

Chemotherapy induced thrombocytopenia in pediatric oncology. (abre nova janela)

Tamamyan G, Danielyan S, Lambert MP

Fonte‎: Crit Rev Oncol Hematol 2016;99:299-307.

Indexado‎: PubMed 26811139

DOI‎: 10.1016/j.critrevonc.2016.01.005

https://www.ncbi.nlm.nih.gov/pubmed/26811139 (abre nova janela)

Oncological management of pediatric cancer patients belonging to Jehovahs Witnesses: a two-institutional experience report. (abre nova janela)

Tenenbaum T, Hasan C, Kramm CM, Janssen G, Laws HJ, Wessalowski R, Bode U, Göbel U

Fonte‎: Onkologie 2004;27(2):131-7.

Indexado‎: PubMed 15138344

DOI‎: 10.1159/000076901

https://www.ncbi.nlm.nih.gov/pubmed/15138344 (abre nova janela)

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. (abre nova janela)

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R.

Fonte‎: Ann Oncol 2005;16(1):139-45.

Indexado‎: PubMed 15598951

DOI‎: 10.1093/annonc/mdi007

https://www.ncbi.nlm.nih.gov/pubmed/15598951 (abre nova janela)

Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. (abre nova janela)

Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, Fackler-Schwalbe I, Fischer J, Gäckle R, Geer T, Harms P, Löffler B, Ohl S, Otremba B, Raab M, Schönrock-Nabulsi P, Strobel G, Winter R, Link H

Fonte‎: Blood 1998;91(10):3601-6.

Indexado‎: PubMed 9572994

https://www.ncbi.nlm.nih.gov/pubmed/9572994 (abre nova janela)